Skip to content

Price / sales at other companies

Baxter International logo
Baxter InternationalBAX
0.8×-0.9×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
4.4×-0.8×
ADMA Biologics logo
ADMA BiologicsADMA
4.2×-6.1×
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
5.1×+0.8×
Biodesix, Inc. logo
Biodesix, Inc.BDSX
1.5×+0.3×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
6.6×-3.5×

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s price / sales?
Lifecore Biomedical, Inc. (LFCR) reported price / sales of 2× in Q1 2025.
How has Lifecore Biomedical, Inc.'s price / sales changed year-over-year?
Lifecore Biomedical, Inc.'s price / sales increased by 45.7% year-over-year, from 1.4× to 2×.
What is the long-term trend for Lifecore Biomedical, Inc.'s price / sales?
Over 4 years (2021 to 2025), Lifecore Biomedical, Inc.'s price / sales has grown at a -9.2% compound annual growth rate (CAGR), from 3× to 2×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.